Skip to content
Search

Latest Stories

Revised SOPs for pharmacy - flexible opening hours, medicines delivery to "shielded" patients

Due to the COVID-19 pandemic, the government has issued a revised standard operating procedure (SOP) for community pharmacies.

The Pharmaceutical Services Negotiating Committee (PSNC) has also revealed further details of new services from the community pharmacy sector to fight the pandemic.


Opening hours flexibility

The updated SOP gives pharmacies some flexibility with the opening and closing times.

According to PSNC, if under significant pressure, pharmacies may now close their doors to the public for up to 2.5 hours a day, including during lunch. This can be done at the discretion of the responsible pharmacist.

Instead of the usual opening hours, community pharmacies can now choose to open between 10am-12 noon and 2pm-4pm as a minimum (if these are contracted core or supplementary hours). These same hours will apply to 100 hours pharmacies.

This has been allowed to ensure that pharmacies can stay open to the public but crucially make sure that pharmacy staff can work safely and are not fatigued by the current high workload and pressures associated with the COVID-19 outbreak.

The pharmacy organisations - PSNC, CCA, NPA and AIM - have all welcomed the revised SOP and the flexibility that this gives to contractors. They are working together on detailed guidance for pharmacy contractors to help them to implement this new SOP.

Medicines delivery service

The government will be helping pharmacies to deliver prescriptions, in the next few days, to around 1.5 million vulnerable patients with serious underlying conditions, who will be instructed to stay at home for a period of 12 weeks so that they are "shielded" from the virus.

The pharmacy negotiator says it is currently concluding discussions with the government about a new national community pharmacy medicines delivery service to support this group of shielded patients.

The new service will be commissioned nationally by the NHS, with associated changes to the "terms of service" for all pharmacies.

The shielded patients will be asked, in the first instance, to have their medicines collected and delivered to them by friends, family or a volunteer, rather than being directed straight to the pharmacy-provided delivery service.

Both patients and contractors will be able to request support from volunteers, who are part of a national volunteer network mobilised in response to the COVID-19 pandemic. Contractors will also be able to request support from these volunteers to undertake deliveries of prescriptions to any patient, not just those that are being shielded.

"We will issue full guidance to contractors as soon as we are able to and we anticipate the service will commence in the next few days," PSNC said in a statement late on Sunday.

NHS 111 online CPCS referrals

The NHS 111 Online service has started making Community Pharmacist Consultation Service (CPCS) referrals to community pharmacies where people need urgent access to their usual prescribed medicines.

PSNC advises pharmacy contractors and their teams should conduct the CPCS consultation in the normal way, adhering to the process which the pharmacist needs to follow with the patient.

The pharmacy is eligible to claim the fee for CPCS cases where consultation is provided by telephone to patients, if there is no clinical need for the patient to be seen in the pharmacy.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less